Join the club for FREE to access the whole archive and other member benefits.

Eduardo Chini

Professor of Pharmacology and Anaesthesiology at the Mayo Clinic, Rochester, Minnesota

Dr. Eduardo Chini is a Professor of Pharmacology and Anesthesiology and the Co-director of the Mayo Clinic Mitochondrial Care Center at the Mayo Clinic College of Medicine in Rochester, Minnesota. Dr. Chini’s research focuses on the fields of metabolism, nutrition, obesity, pharmacology, cancer and aging, and kidney disease.

In particular, Dr. Chini is interested in nicotinamide adenine dinucleotide (NAD) metabolism and functions. He and his colleagues are exploring the nonoxidative and oxidative roles of NAD (as a signaling molecule and energy coin in cells). Dr. Chini's laboratory has done seminal work on NAD catabolism, including the description of the main enzyme responsible for the degradation of this molecule in mammalian tissues. Dr. Chini has published over 150 manuscripts in the field.

The ultimate goal of Dr. Chini's research is to provide new avenues for the development of novel and effective pharmacological therapeutic approaches for human diseases such as obesity, metabolic syndrome, aging-related disease and kidney disease, and their complications.

Visit website:


See also: Health Organisation Mayo Clinic - Non-profit American academic medical center focused on health care, education, and research

Details last updated 28-Jun-2020

Eduardo Chini is also referenced in the following:

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

Eduardo Chini News

CD38 inhibitor increases lifespan and fitness in male mice (LEAF) - 05-Apr-2022

New anti-ageing approach to ramp up NAD levels and life extension


CD38 enzyme: the culprit behind age related metabolic diseases

Mayo Clinic - 14-Jun-2016

The focus is to find ways to keep up the NAD levels in tissues with ageing